AVEERA MEDICAL INC.

SAN CLEMENTE, CA · Founded 2020 · CIK 0002018044 · Medtech · Private

Boomerang System for native Deep Vein Arterialization (nDVA) procedure to restore blood flow in chronic limb-threatening ischemia

Grants
$1.0M
1 award
Sector median: 1
Raised
$8.8M
2 Form D · Feb 2026
7 months since last filing
Contracts
—
No federal contracts on record
Patents
6
0 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,469,765
Federal grantDepartment of Health and Human Services · Phase II · Preventing major amputations and preserving functional limbs in no option critical limb-threating ischemia patients$1,032,585
Private capital raisedForm D · SEC$5,351,737
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
801MICROVASCULAR TISSUES, INC.—$12M
802THERAHEART INC.—$12M
803LADERX LLC—$67K
804AVEERA MEDICAL INC.—$8.8M
805NANOCAN THERAPEUTICS CORPORATION—$6.2M
806XCath, Inc.—$5.3M
807Prenosis, Inc.—$1.6M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Ed ChangDirector
  • Brian DriscollExecutive Officer
  • Jeffrey HullDirector
  • Steve ParkerDirector
  • Mark RitchartDirector
  • Joseph SteeleDirector · Executive Officer · Promoter

Patents

USPTO · 0 granted of 6
  • Medical Systemapplication
  • Medical Systemapplication
  • Medical Systemapplication
  • Medical Systemapplication
  • Medical Systemapplication
  • Medical Systemapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.